Future therapies for chronic Hepatitis B and the role of diagnostics
Future therapies for chronic Hepatitis B and the role of diagnostics Read More »
Immunoassay
The roles of biomarkers in preeclampsia management
Angiogenic biomarkers have been shown to improve the clinical management of preeclampsia. Preeclampsia is a placental disease caused by trophoblast dysfunction. The angiogenic factors placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1), all originating at least in part from the trophoblast, are biomarkers with predictive potential for preeclampsia and related adverse outcomes. The 60-minute webinar focuses on how
The roles of biomarkers in preeclampsia management Read More »
The use of NT-proBNP in hospital and ambulatory settings: Translating the evidence to clinical practice
NT-proBNP has been proven to be a useful biomarker for prognostic evaluation of chronic heart failure patients, but it remains unclear how prognostic evidence can be translated into clinical practice to enhance heart failure management. The Asia Pacific Cardiac Webinar brings together global and regional experts to discuss the practical use of NT-proBNP as a
Transforming heart failure care at Huelva University Hospital, Spain
We recently began a study at our laboratory to determine the patient value of new diagnostic markers, in particular natriuretic peptides, to the management of heart failure. We selected heart failure because it has reached epidemic levels in our population, with many requiring multiple admissions to the hospital to manage their condition. Our research process
Transforming heart failure care at Huelva University Hospital, Spain Read More »
Immunoassay interferences: Facts, insights and a pragmatic approach
Full presentation by Dr. Nam K Tran delivered to healthcare and laboratory medicine leaders at the Roche Efficiency Days (RED) 2018: REDefining perspectives in Guangzhou, China. Interfering substances serve as confounding factors in laboratory testing. These interfering substances may be endogenous or exogenous in nature. Endogenous interferences could be due to the patient’s physiologic state. Alternately, common exogenous interferences
Immunoassay interferences: Facts, insights and a pragmatic approach Read More »
Putting biotin interference in context
Lab specialists are bombarded by warnings aimed at preventing diagnostic errors or test interference, and with good reason—errors are common in healthcare. However, laboratories boast lower error rates than clinical healthcare [1]. Most errors that do occur (46-68.2% of them) are pre-analytic, such as order entry errors, getting an insufficient sample volume, or labeling the sample
Putting biotin interference in context Read More »
